BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2
R. Camille Brewer, Nitya S. Ramadoss, Lauren J. Lahey, Shaghayegh Jahanbani, William H. Robinson, Tobias V. Lanz
Topics & Concepts
AntibodyMemory B cellNeutralizing antibodyProtein subunitVirologyMedicineImmunologyMessenger RNAVaccinationCoronavirusSevere acute respiratory syndrome coronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Spike ProteinReceptorB cellBiologyCoronavirus disease 2019 (COVID-19)GeneGeneticsDiseasePathologyInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesT-cell and B-cell Immunology